Fortis Healthcare

807.05
+13.00
(1.64%)
Market Cap
59,947.50 Cr
EPS
10.26
PE Ratio
71.95
Dividend Yield
0.12 %
52 Week High
802.90
52 Week Low
453.00
PB Ratio
6.83
Debt to Equity
0.14
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from12 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Fortis Healthcare plans to add 900 beds next year, aiming for 14-15% revenue growth in FY26. The company's hospital segment showed strong 14% YoY revenue growth in Q4 FY25, with improved occupancy and ARPOB. The diagnostics segment, rebranded as Agilus, is expected to show stronger performance from FY26. Analysts maintain 'Outperform' rating on the stock.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,298.20
#1 1,26,515.20
111.47
7,028.46
18.77
1,070
26.84
66.67
7,553.50
1,08,773.10
75.12
#1 21,794.00
14.74
1,513
60.41
70.65
807.05
#3 59,947.50
#5 71.95
#2 7,782.75
#10 8.99
#4 809
#8 -7.43
67.42
2,011.40
40,992.70
#1 51.59
5,482.98
10.96
807
3.41
55.67
633.15
33,680.50
88.45
4,138.46
22.85
#1 5,417
#1 3,986.36
66.33
1,183.80
31,978.00
61.28
3,692.32
#1 25.09
486
-20.35
52.92
686.05
26,959.40
72.89
3,035.10
12.94
409
48.39
57.58
1,599.40
16,107.10
68.30
1,566.90
17.46
244
10.57
66.99
1,506.50
9,772.60
52.43
1,290.20
17.77
194
-0.88
55.50
566.30
7,631.60
177.55
2,218.14
12.97
28
-71.06
58.80
Forecast
Actual
Growth Rate
Revenue Growth
8.99 %
Net Income Growth
1.93 %
Cash Flow Change
33.79 %
ROE
-3.46 %
ROCE
14.14 %
EBITDA Margin (Avg.)
3.01 %

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
Fixed Assets
4,218
3,776
5,419
4,992
8,477
8,802
8,799
9,416
9,426
9,874
6,636
Current Assets
1,636
1,434
1,775
1,282
1,667
941
1,037
1,133
1,406
1,421
1,471
Capital Work in Progress
228
201
268
226
450
204
165
194
228
542
404
Investments
616
1,449
1,878
1,732
270
175
186
104
210
230
115
Other Assets
2,554
1,807
2,152
1,672
2,755
2,167
2,005
2,172
2,569
2,643
0
Total Liabilities
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
Current Liabilities
1,602
1,476
1,927
2,134
3,591
2,579
1,233
1,269
1,426
3,170
1,607
Non Current Liabilities
1,813
1,616
1,480
1,171
1,248
1,563
3,204
3,607
2,907
1,563
2,915
Total Equity
4,201
4,140
6,311
5,317
7,113
7,206
6,718
7,008
8,100
8,556
8,917
Reserve & Surplus
3,585
3,534
4,626
3,543
5,846
5,906
5,365
5,423
6,487
6,908
8,162
Share Capital
463
463
518
519
755
755
755
755
755
755
755

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-66
-38
225
-513
799
-627
212
-153
-22
125
Investing Activities
213
122
-1,001
-333
-3,279
64
-131
-501
-373
-889
Operating Activities
24
195
967
493
-179
172
486
865
822
1,100
Financing Activities
-304
-354
259
-672
4,257
-862
-143
-517
-471
-87

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
26.32 %
0.00 %
23.24 %
23.31 %
25.26 %
26.77 %
27.40 %
DIIs
13.44 %
15.20 %
15.66 %
15.50 %
16.72 %
17.44 %
19.94 %
20.38 %
20.70 %
22.16 %
26.55 %
29.35 %
31.15 %
32.31 %
30.73 %
30.05 %
29.46 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.96 %
15.16 %
15.98 %
14.89 %
13.96 %
13.58 %
12.92 %
12.39 %
12.05 %
11.80 %
11.13 %
11.04 %
10.82 %
10.47 %
10.36 %
10.21 %
10.22 %
Others
41.43 %
38.47 %
37.20 %
38.44 %
38.15 %
37.82 %
35.98 %
36.06 %
36.08 %
34.86 %
4.83 %
28.44 %
3.63 %
2.75 %
2.48 %
1.81 %
1.75 %
No of Share Holders
0
1,09,889
1,44,634
1,66,743
1,54,572
1,56,881
1,60,762
1,58,455
1,37,894
1,35,047
1,31,516
1,35,664
1,57,165
1,54,260
2,04,184
2,21,750
2,18,329

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.14 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 662.35 679.70
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 628.55 650.15
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 614.10 620.90
02 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
02 Aug 2024 458.65 505.45
24 Jul 2024 DIVIDEND Dividend
₹ 1.00 /share
24 Jul 2024 468.95 483.05
20 Jul 2023 DIVIDEND Dividend
₹ 1.00 /share
20 Jul 2023 287.60 334.95

Announcements

Disclosure On Completion Of Term Of Independent Director7 days ago
Announcement under Regulation 30 (LODR)-Resignation of Director7 days ago
Announcement under Regulation 30 (LODR)-Resignation of Director7 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate7 days ago
Closure of Trading Window8 days ago
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Updates On Acquisition - Shrimann HospitalMay 28, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Statement Of Utilization And Deviation Or Variation In The Use Of Proceeds Of Issue Of Listed Non-Convertible Debentures (Ncds)May 20, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).May 20, 2025
Compliance With Respect To The Regulation 56(1)(D) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 And Other Relevant Provisions.May 20, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
Compliances-Reg. 54 - Asset Cover details May 20, 2025
Revision In Policies.May 20, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
Appointment Of Secretarial Auditors And Cost Auditors.May 20, 2025
Corporate Action-Board approves DividendMay 20, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 20, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015May 20, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015May 20, 2025
Reschedule Of Investors/ Ananlysts CallMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015May 05, 2025
Disclosure Under Chapter XIV - Centralized Database For Corporate Bonds/ Debentures Of SEBI Master Circular Dated May 22 2024.Apr 30, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 25, 2025
Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017) Apr 10, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 02, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) - Regarding Fortis Trademarks And Allied Trademarks.Apr 02, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 21, 2025
Update On Acquisition Announcement Dated February 14 2025Mar 21, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 20, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 20, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015.Mar 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Acquisition Of Shrimann Superspecialty Hospital.Feb 14, 2025

Technical Indicators

RSI(14)
Neutral
67.42
ATR(14)
Less Volatile
19.59
STOCH(9,6)
Neutral
78.14
STOCH RSI(14)
Neutral
67.36
MACD(12,26)
Bullish
0.94
ADX(14)
Strong Trend
36.62
UO(9)
Bearish
56.01
ROC(12)
Uptrend And Accelerating
6.33
WillR(14)
Overbought
-3.57

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Mirae Asset Large & Midcap Fund Direct-Growth
0.17%
-1798989
-0.33%
-0.65%
HDFC Small Cap Fund Direct- Growth
2.09%
-1267000
-0.43%
-0.79%
Edelweiss Mid Cap Direct Plan-Growth
2.02%
511420
0.27%
0.15%
Edelweiss Small Cap Fund Direct - Growth
1.59%
235204
0.30%
0.22%
Baroda BNP Paribas Midcap Fund Direct-Growth
1.65%
200000
0.64%
1.65%
Kotak Large & Midcap Fund Direct-Growth
0.71%
200000
0.04%
0.07%
Bandhan Midcap Fund Direct-Growth
0.79%
189070
0.79%
0.79%
Sundaram Multi Asset Allocation Fund Direct - Growth
0.49%
181000
0.49%
0.49%
Axis Large & Mid Cap Fund Direct-Growth
1.36%
177546
0.07%
0.00%
Bandhan Large Cap Fund Direct-Growth
0.48%
126392
0.48%
0.48%
Kotak Contra Fund Direct-Growth
1.84%
120000
0.16%
0.29%
Shriram Multi Sector Rotation Fund Direct-Growth
5.92%
112900
4.15%
2.97%
LIC MF Aggressive Hybrid Fund Direct-Growth
1.36%
102235
1.36%
1.36%
Bandhan Innovation Fund Direct-Growth
0.47%
101199
0.47%
0.47%
WhiteOak Capital Mid Cap Fund Direct - Growth
1.78%
89643
0.10%
0.60%
Bajaj Finserv Consumption Fund Direct-Growth
1.05%
85000
1.05%
1.05%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.66%
83880
0.66%
0.66%
Aditya Birla Sun Life Large & Mid Cap Fund Direct -Growth
1.45%
-80711
-0.12%
-0.17%
Bajaj Finserv Healthcare Fund Direct-Growth
1.72%
78000
1.72%
1.72%
Mirae Asset Healthcare Fund Direct - Growth
2.45%
75000
0.26%
0.15%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
5.12%
74839
1.58%
1.31%
JM Midcap Fund Direct - Growth
1.52%
-72500
-0.42%
-0.55%
Edelweiss Consumption Fund Direct-Growth
1.05%
53945
1.05%
1.05%
Kotak Nifty Midcap 150 Momentum 50 Index Fund Direct-Growth
3.19%
41759
-0.09%
-0.27%
Nippon India Active Momentum Fund Direct-Growth
1.61%
41018
1.61%
1.61%

About Fortis Healthcare

Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(18 Years, -4 days)
Chairperson NameLeo Puri